Board certified hematopathologist reviews bone marrow and lymphoma cases.
Comprehensive integrated summary reports issued at the completion of all bone marrow cases and ancillary testing that incorporate all findings.
One pathologist oversees your case from start to finish.
Breast prognostic and predictive markers (Her2/neu by IHC and FISH, ER, PgR, Ki-67, p53) performed on all new breast cancers with results within 24 hours (FISH reported within 3 business days). Computer-assisted quantitative image analysis of all breast prognostic immunohistochemical markers for increased accuracy.
Board certified cytopathologists interpret FNA and cytology specimens.
Molecular & Other Testing
Predictive and prognostic tests automatically performed on all relevant malignant cases for rapid results. Offerings include: EGFR, ALK, ROS1, PD-L1, Mismatch repair proteins, BRAF, KRAS, HER2, KIT/PDGFRA, p16.
Our pathologists have advanced knowledge in molecular testing and can offer guidance on test selection and interpretation.
FISH for myelodysplasia, lymphoma, leukemia, and myeloma interpreted by our pathologists. Flow cytometry interpreted by our pathologists, performed on all bone marrow cases.
Our lab will facilitate sending out any additional specialized molecular tests to other labs.
Jianming James Yin, M.D., Ph.D., Hematopathology